The molecular background has been elucidated for a large part of familial forms of the disease, caused by constitutional mutations in the multiple endocrine neoplasia type 1 gene (MEN1),the hyperparathyroidism-jaw tumour syndrome gene (HRPT2) or the calcium sensing receptor gene (CASR). The gene discussed is CASR; the disease is neoplastic syndrome.